SCHEMBL28028705

SCHEMBL28028705

COC(=O)C(F)C(F)CCc1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 1/20 0.47
▸ SMN1; SMN2 Q16637 4/20 0.47
▸ KMT2A Q03164 3/20 0.45
▸ MEN1 O00255 1/20 0.45
▸ HTT P42858 1/20 0.45
▸ HPGD P15428 1/20 0.45
▸ ALDH1A1 P00352 2/20 0.45
▸ CNR2 P34972 1/20 0.44
▸ POLB P06746 1/20 0.43
▸ MAPT P10636 1/20 0.43
▸ L3MBTL1 Q9Y468 1/20 0.43
▸ MME P08473 1/20 0.42
▸ MMP12 P39900 1/20 0.42
▸ NPC1 O15118 1/20 0.42
▸ RAB9A P51151 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6881940 0.83 TSHR (0.50) TSHRSMN1; SMN2KMT2AMEN1HTT
SCHEMBL28044466 0.83 ATM (0.50) KMT2AMEN1ALDH1A1POLBMAPT
SCHEMBL6630548 0.83 TSHR (0.50) TSHRSMN1; SMN2KMT2AMEN1HTT
SCHEMBL28028204 0.81 CNR2 (0.46) TSHRSMN1; SMN2KMT2AMEN1HTT
SCHEMBL7056381 0.80 TSHR (0.53) TSHRSMN1; SMN2KMT2AMEN1HTT
SCHEMBL6574637 0.78 TSHR (0.65) TSHRSMN1; SMN2KMT2AMEN1HTT
SCHEMBL121124 0.78 TSHR (0.65) TSHRSMN1; SMN2KMT2AMEN1HTT
SCHEMBL2935426 0.78 TSHR (0.51) TSHRSMN1; SMN2KMT2AMEN1HTT
SCHEMBL6628027 0.78 TSHR (0.51) TSHRSMN1; SMN2KMT2AMEN1HTT
SCHEMBL6632225 0.78 TSHR (0.51) TSHRSMN1; SMN2KMT2AMEN1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102014635-B Difluoro-containing compounds as cysteine protease inhibitors VIROBAY, INC. (US) 2015-12-16 — — CN disclosed
CN-102417480-B As the Spirocyclic nitriles of proteinase inhibitor Sanofi-Aventis S. P. A. (FR) 2015-08-26 — — CN disclosed
Send feedback